<DOC>
	<DOC>NCT01986452</DOC>
	<brief_summary>Apoplexy patients with OSA are often not receiving a CPAP therapy due to generally poor acceptance and adherence. There is a great potential to significantly improve the treatment and care of these patients in a time economic way by telemonitoring the therapy in home environment. This study is planned to prove that telephone consultancy and motivation in times of recorded decreasing CPAP therapy usage can improve adherence, neurological function and quality of life.</brief_summary>
	<brief_title>Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA</brief_title>
	<detailed_description>Eligible patients with confirmed OSA from neurological rehab department of Helios Clinic Hagen Ambrock are asked to join the study. They will be randomly assigned to one of two arms [CPAP with Telemonitoring (MTM) or without Telemonitoring (OTM)] for 6 months of home treatment after hospital discharge. The MTM arm will receive supporting phone calls when the monitored usage time decreases.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>s/p ACM (Arteria Cerebri Media Insult) Diagnosed OSA AHI &gt;15/h Barthel Index item 8 &gt; 5 points (or home assistance) Life expectancy &gt;6 month Capable of giving consent Already existing ventilatory support (CPAP, NIV etc) Central AI &gt;50% baseline Central AI &gt;5/h under CPAP therapy Drug abuse Pregnant or nursing women Participation in another clinical trial last 4 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>OSA</keyword>
	<keyword>Apoplexy</keyword>
	<keyword>CPAP</keyword>
	<keyword>adherence</keyword>
	<keyword>telemonitoring</keyword>
</DOC>